Factors Influencing Visualization of the Intracranial Translucency during First-Trimester Screening for Aneuploidy

Abstract

Objective Neural tube defects occur in 1/2000 live births. Imaging of the intracranial translucency (IT) during first-trimester screening has been proposed as an early screen for open neural tube defects (ONTD). This study evaluates visualization of the IT and factors influencing its visualization during first-trimester ultrasound screening for aneuploidy.

Methods Ultrasound images for patients undergoing first-trimester screening for aneuploidy from January 1, 2009, through July 31, 2009, were reviewed for IT visualization, defined as an intracranial translucency parallel to the nuchal translucency. Second-trimester ultrasounds and delivery records were reviewed for the presence of fetal ONTD.

Results The IT was visualized in 74.8% of 759 gestations studied at a mean gestational age of 12 weeks, 5 days. Among gestations where the IT was visualized, we found a larger crown-rump length, lower maternal weight, and more fetuses in the supine position (p < 0.0001). Predictive models for visualization of the IT were formulated based on these factors.

Conclusion The IT can be visualized in the majority of patients in the standard midsagittal plane used for measurement of the nuchal translucency. Visualization is significantly associated with crown-rump length, gestational age, maternal weight, and fetal position. Visualization of the IT is feasible.

Keywords

first-trimester screening - neural tube defect - intracranial translucency

• References

• 1 Callen P. Ultrasonography in Obstetrics and Gynecology. Philadelphia, PA: Saunders; 2008: 349
• 2 Bernard JP, Suarez B, Rambaud C, Muller F, Ville Y. Prenatal diagnosis of neural tube defect before 12 weeks' gestation: direct and indirect ultrasonographic semeiology. Ultrasound Obstet Gynecol 1997; 10: 406-409
• 3 Sebire NJ, Noble PL, Thorpe-Beeston JG, Snijders RJ, Nicolaides KH. Presence of the “lemon” sign in fetuses with spina bifida at the 10–14-week scan. Ultrasound Obstet Gynecol 1997; 10: 403-405
• 4 Chaoui R, Benoit B, Mitkowska-Wozniak H, Heling KS, Nicolaides KH. Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11–13-week scan. Ultrasound Obstet Gynecol 2009; 34: 249-252
• 5 Chaoui R, Nicolaides KH. From nuchal translucency to intracranial translucency: towards the early detection of spina bifida. Ultrasound Obstet Gynecol 2010; 35: 133-138
• 6 Nicolaides KH, Campbell S, Gabbe SG, Guidetti R. Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet 1986; 2: 72-74
• 7 Becker R, Wegner RD. Detailed screening for fetal anomalies and cardiac defects at the 11–13-week scan. Ultrasound Obstet Gynecol 2006; 27: 613-618
• 8 Coerdt W, Miller K, Holzgreve W, Rauskolb R, Schwinger E, Rehder H. Neural tube defects in chromosomally normal and abnormal human embryos. Ultrasound Obstet Gynecol 1997; 10: 410-415
• 9 Sepulveda W, Wong AE, Fauchon DE. Fetal spinal anomalies in a first-trimester sonographic screening program for aneuploidy. Prenat Diagn 2011; 31: 107-114
• 10 Buisson O, De Keersmaecker B, Senat MV, Bernard JP, Moscoso G, Ville Y. Sonographic diagnosis of spina bifida at 12 weeks: heading towards indirect signs. Ultrasound Obstet Gynecol 2002; 19: 290-292
• 11 Aagaard-Tillery KM, Flint Porter T, Malone FD , et al. Influence of maternal BMI on genetic sonography in the FaSTER trial. Prenat Diagn 2010; 30: 14-22
• 12 D'Alton ME, Cleary-Goldman J, Lambert-Messerlian G , et al. Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial. Ultrasound Obstet Gynecol 2009; 33: 142-146
• 13 de Graaf IM, Müller MA, van Zuylen-Vié AA, Bleker OP, Bilardo CM. The influence of fetal position on nuchal translucency thickness. Ultrasound Obstet Gynecol 2000; 15: 520-522